VP-16
Showing 26 - 50 of 6,249
Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma
Not yet recruiting
- Double-Expressor Lymphoma
- +3 more
- Cyclophosphamide
- +6 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 27, 2022
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent
Not yet recruiting
- Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
- +21 more
- Biopsy
- +8 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 7, 2023
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small
Recruiting
- Desmoplastic Small Round Cell Tumor
- +11 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jun 26, 2022
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United
Recruiting
- Acute Adult T-Cell Leukemia/Lymphoma
- +3 more
- Cyclophosphamide
- +5 more
-
Atlanta, Georgia
- +13 more
Jan 26, 2023
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Carboplatin
- +5 more
-
Jacksonville, Florida
- +11 more
Jan 12, 2023
AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)
Recruiting
- AML, Adult
- QN-023a
- +4 more
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022
Leukemia Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- cyclophosphamide
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Variegate Porphyria Trial in Rotterdam (Afamelanotide 16 MG)
Recruiting
- Variegate Porphyria
- Afamelanotide 16 MG
-
Rotterdam, NetherlandsCLINUVEL investigational site
May 3, 2023
Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- Durvalumab
- +3 more
- (no location specified)
Jun 5, 2023
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)
Not yet recruiting
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Bone Marrow Aspiration and Biopsy
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 11, 2022
Refractory or Relapsed B Cell Lymphoma Trial in Chongqing (ThisCART19A, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Refractory or Relapsed B Cell Lymphoma
- ThisCART19A
- +3 more
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 8, 2023
Richter Syndrome, Chronic Lymphocytic Leukemia Trial in New York (Polatuzumab Vedotin, Rituximab, Etoposide)
Recruiting
- Richter Syndrome
- Chronic Lymphocytic Leukemia
- Polatuzumab Vedotin
- +5 more
-
New York, New YorkWeill Cornell Medicine
Dec 19, 2022
Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 21, 2023
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell
Completed
- AIDS-related Diffuse Large Cell Lymphoma
- +8 more
- cyclophosphamide
- +7 more
-
Eldoret, Kenya
- +1 more
Sep 12, 2022
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Hematological Malignancy
- Etoposide
- +2 more
-
Ningbo, Zhejiang, ChinaThe Affiliated People's Hospital of Ningbo University.
Aug 18, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
- etoposide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 19, 2022
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +2 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,
Terminated
- Leukemia
- +2 more
- Ciprofloxacin 750 MG
- +3 more
-
Gainesville, FloridaUF Health Shands Cancer Hospital
Jul 5, 2022
Medulloblastoma Trial in Memphis (procedure, drug, radiation)
Recruiting
- Medulloblastoma
- Surgical resection
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 16, 2022